Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene Delivery


Authors: E. Quagliarini, S. Renzi, L. Digiacomo, F. Giulimondi, B. Sartori, H. Amenitsch, V. Tassinari, L. Masuelli, R. Bei, L. Cui, J. Wang, A. Amici, C. Marchini, D. Pozzi, and G. Caracciolo

Journal:

DOI: https://doi.org/10.3390/pharmaceutics13081292

Publication - Abstract

August 19, 2021

DNA Nucleic Acid Lipid Nanoparticles Oncology
With recent successes reflected in literature on mRNA delivery using LNPs, scientists from the University of Rome set out to investigate whether that success can be achieved with plasmid DNA delivery using LNPs (pDNA-LNPs). Authors Quagliarini et al. 2021 synthesized pDNA-LNPs using the NanoAssemblr’s tunable microfluidic technology and the impact of characteristics such as size and composition, and process parameters such as total flow rate (TFR) on in vitro transfection efficiencies were assessed. As a result, the paper illustrates small-sized homogenous pDNA-LNPs are capable of a higher transfection efficiency with lower cytotoxicity in three cell lines when compared to the conventional transfection agent Lipofectamine™ 3000. In vitro validation of the pDNA-LNPs in the study showcases precise control over composition through manipulation of TFRs and addition of PEGylation built into the bottom-up approach of NanoAssemblr® technology. Given this article’s assessment of pDNA-LNP physiochemical characteristics, further research can be conducted to accelerate the development of DNA-based vaccines, cancer immunotherapies, and gene therapies.

limit search to this category
Advanced Search

Advanced Search

close
  • Publications
  • Application Notes
  • Posters
  • Workshops
  • Videos & Webinars
  • Articles
Search

Browse by Category

  • Application
    • Diagnostic and Imaging
    • Genetic Medicine
    • Hematology
    • Metabolic Disorders
    • Neuroscience
    • Oncology
    • Skeletal Disorders
    • Targeted Drug Delivery
    • Vaccines
    • Other Applications
    • Cell therapy
  • Formulation
    • Liposomes
    • Nucleic Acid Lipid Nanoparticles
    • Polymeric Nanoparticles
    • Other Formulations
  • Payload
    • DNA
    • microRNA
    • mRNA
    • siRNA
    • Small Molecule Drugs
    • Other Payloads


related content

Publication - Abstract

Apr 06, 2020
ACS Nano

Cationic Amphiphilic Drugs Boost the Lysosomal Escape of Small Nucleic Acid Therapeutics in a Nanocarrier-Dependent Manner

T. Van de Vyver, B. Bogaert, L. De Backer, F. Joris, R. Guagliardo, J. Van Hoeck, P. Merckx, S. Van Calenbergh, S. Ramishetti, D. Peer, K. Remaut, S.C. De Smedt, and K. Raemdonck

siRNA Nucleic Acid Lipid Nanoparticles Other Applications
Small nucleic acid (NA) therapeutics, such as small interfering RNA (siRNA), are generally formulated in nanoparticles (NPs) to overcome the multiple extra- and intracellular barriers upon in vivo administration. Interaction with target cells typically triggers endocytosis and se...
Read More


Publication - Abstract

Sep 24, 2019
Nature Communications

Linkage Between Endosomal Escape of LNP-mRNA and Loading into EVs for Transport to Other Cells

M. Maugeri, M. Nawaz, A. Papadimitriou, A. Angerfors, A. Camponeschi, M. Na, M. Hölttä, P. Skantze, S. Johansson, M. Sundqvist, J. Lindquist, T. Kjellman, I.-L. Mårtensson, T. Jin, P. Sunnerhagen, S. Östman, L. Lindors, and H. Valadi

Nucleic Acid Lipid Nanoparticles mRNA
RNA-based therapeutics hold great promise for treating diseases and lipid nanoparticles (LNPs) represent the most advanced platform for RNA delivery. However, the fate of the LNP-mRNA after endosome-engulfing and escape from the autophagy-lysosomal pathway remains unclear. To inv...
Read More


Sign Up and Stay Informed
Sign up today to automatically receive new Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.
Sign Up